Research article · 30 Mar 2021
Research articlePublished 21 May 2021
In Search for the Truth about Hydroxychloroquine Prophylaxis of Covid-19
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Introduction: COVID-19, caused by the coronavirus SARS-CoV-2 has quickly spread around the world. Currently there is an active search for vaccines and therapeutics, including repurposing of well-known drugs. COVID-19 continues to be a challenge with only a few therapeutic and no chemoprophylactic interventions to combat the virus. Methods: We aimed to review available data for the application of hydroxychloroquine (HCQ) as a chemoprophylactic agent for COVID-19, outline weakness of published trials and assess the objectivity of conclusions regarding the possible benefits of HCQ prophylaxis against the novel coronavirus disease. Results: Our search turned 15 articles describing trials investigating the application of HCQ as a chemoprophylactic agent for COVID-19. Different cohorts of subjects were used, mainly health care workers exposed to coronavirus patients; people with rheumatic arthritis and systemic lupus erythematosus; cases of household transmission. Conclusions: Trials investigating the potential of HCQ to be a prophylactic agent for SARS-CoV-2 have quite conflicting results. Further research is required in the form of large randomized trials with carefully considered methodological approach which will help avoid limitations making the potential results unreliable.
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 29 Nov 2022
Reconsidering Chloroquine and Hydroxychloroquine in Treatment of COVID-19: Lessons learnt
Short communication · 26 Oct 2020
Do Chloroquine and Hydroxychloroquine Treat COVID-19?
Review article · 5 Oct 2020
Is there a Correlation between Changes in Hydroxychloroquine Use and Mortality Rates from COVID-19?
Case report · 27 May 2020
Successful Treatment of COVID-19 Pneumonia using Hydroxychloroquine, Azithromycin, and Tocilizumab
More from this journal
The newest in Health Science Journal.
Editorial · 31 Dec 2025
Energy-Boosting Nutrition: Fueling the Body for Optimal Performance and Vitality
Editorial · 31 Dec 2025
Digestive Balance: Maintaining a Healthy Gut for Optimal Digestion and Well-being
Editorial · 31 Dec 2025
Prebiotics: Exploring the Role of Dietary Components in Supporting Gut Health and Overall Wellness
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalHealth Science Journal
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Elena Filipova”
- BylineArticles whose byline prints “Elitsa Gotseva”
- BylineArticles whose byline prints “Katya Uzunova”
- BylineArticles whose byline prints “Velichka Pavlova”
- BylineArticles whose byline prints “Silvia Hristova”
- BylineArticles whose byline prints “Toni Vekov”

